Vinyas Innovative Technologies LtdQ1 FY25Industrial Manufacturing

Vinyas Innovative Technologies Ltd

Q1 FY25 Earnings Call Analysis

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Revenue guidance

Category 2

→Vinyas expects a 25% year-on-year revenue growth for FY ’26.
→Current order inflow is expected to be at similar levels as FY ’25, around Rs. 600 to 750 crores.
→The confirmed order book is anticipated to grow from Rs. 1,018 crores to about Rs. 1,500 to 1,600 crores by the end of FY ’26.
→Full optimal utilization of current capacity is expected by FY ’27.
→Current capacity can support Rs. 1,200 to 1,400 crores in revenue without incremental investment.
→The company targets Rs. 1,000+ crore revenue by FY ’27 but is cautious in committing exact figures.
→There is a 25%-30% year-on-year growth projected over the next few years.
→Order execution timelines span 12 to 18 months primarily.
→Expansion into new segments like commercial aerospace and medical devices aims to support growth.

Category 3

→Vinyas Innovative Technologies anticipates 25% year-on-year revenue growth for FY '26.
→EBITDA margin is expected to remain stable between 9% to 11% over the next 2-3 years.
→Net profit growth of 27% was achieved in FY '25, indicating strong profitability momentum.
→EPS for FY '25 was 15.43, with a second half EPS of 9.86, reflecting improved performance.
→The margin profile is expected to stay consistent for the next two to three years with operational efficiencies.
→Potential margin improvement is limited in the near term; any increases would take more time.
→The company plans to leverage growth from defense and aerospace sectors and the medical device segment.
→Working capital and capacity expansions are in line to support growing order books without significant margin dilution.

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for Vinyas Innovative Technologies Ltd and 1,400+ other companies.

→No explicit mention of any new fundraising through debt or equity in the call transcript.
→Current debt-to-equity ratio stands healthy at 0.7x.
→Company has sufficient unutilized non-fund based bank limits for working capital and operational readiness.
→Incremental CAPEX plans primarily focus on adding SMT lines (~Rs. 30 crore per line) and small critical equipment (~Rs. 2-3 crore yearly).
→Working capital is currently sufficient to support growth for this and next financial year, with advances from customers helping the requirement.
→Any major future financing needs will be assessed and communicated later as per evolving business needs.

Yes

→Current order book stands at about Rs. 1,018 crores as of June 4, 2025.
→Execution timeline for the order book is between 12 to 18 months.
→Order inflow expected in FY '26 is between Rs. 600 to 750 crores, similar to FY '25 levels.
→The confirmed order book is expected to grow to about Rs. 1,500 to 1,600 crores by the end of FY '26, reflecting 25% growth.
→The order book composition is roughly 80% defense, 15-18% industrial, and the balance medical.
→Approximately 80% of the order book pertains to Make in India programs, with most offset programs having largely completed.
→Export orders make up about 22-23% of the current orders.
→No substantial development has occurred this financial year on the build-to-spec side for medical devices.

Yes

→Incremental CAPEX mainly involves adding more SMT lines, with a rule of thumb of Rs. 600 crores revenue per SMT line on defense and aerospace side.
→Recent expansion involved Rs. 30 crores CAPEX to add a second SMT line; similar level expected for each new line.
→Yearly CAPEX of Rs. 2-3 crores planned for other critical equipment to support programs.
→Current capacity expansion can support Rs. 1,200 to Rs. 1,400 crores revenue without major additional CAPEX.
→Working capital is sufficient for this and next financial year; additional funding to be explored afterward as needed.
→No major backward integration CAPEX currently planned, as electronic components are low volume and predominantly imported.
→Future investments also include equipment upgrades for quality and process improvements as programs mature.

How does Vinyas Innovative Technologies Ltd rank vs peers in Industrial Manufacturing?

Pro feature

1Vinyas Innovative Technologies Ltd

Rev 2Mar 3

See full Industrial Manufacturing sector rankings

Want more stocks like Vinyas Innovative Technologies Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.